Marc Fröhlich

Marc Fröhlich is the current CEO at Akroswiss. Prior to this, they were a consultant at Monitor Deloitte from April 2016 to March 2019, where they worked on corporate strategy refresh for a Japanese pharmaceutical company, digital vision and strategy definition for a Swiss industrial engineering and manufacturing company, disease and market landscape assessment for a Japanese pharmaceutical company, marketing capabilities diagnosis for a Swiss pharmaceutical company, and digital excellence for a Swiss pharmaceutical company. From June 2015 to August 2015, they were a student consultant at Capgemini Consulting, where they worked on professionalization and streamlining of back-office processes for a German Landesbank and conceptualization of a finance- and risk architecture for an Austrian retail bank. Marc has also held internships at UBS Wealth Management, Bayer Business Consulting, and Wurth Group of North America.

Marc Fröhlich's educational career began with him obtaining a B.A. HSG in Business Administration from Universität St. Gallen-Hochschule für Wirtschafts-, Rechts- und Sozialwissenschaften. Marc then went on to obtain a Master of Science (MSc) in Accounting and Finance from the Stockholm School of Economics. Lastly, they obtained their Master's Degree in International Business from CEMS.

Some individuals on their team include John Fröhlich - Founder & Chief Science Officer, Walter P. Hölzle - Head of Business Development, and Jonas Steinhauser - Research & Development Director.